DrugInserts.com: Trustworthy FDA Drug Information

Vaccines and Other Medical Materials

Vaccines and Other Medical Materials Updated During December 2011, From Oldest to Newest

Page 1 of 2 1 2 »

ADVATE

Antihemophilic Factor, Human Recombinant

By Baxter Healthcare Corporation | Last revised: 9 December 2011
ADVATE

ADVATE is an Antihemophilic Factor (Recombinant) indicated for: Control and prevention of bleeding episodes in adults and children (0-16 years) with Hemophilia A(1.1) Perioperative management in adults and children (0-16 years) with Hemophilia A (1…

Menactra

NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOI

By Sanofi Pasteur Inc. | Last revised: 13 December 2011
Menactra

Menactra ®. Meningococcal (Groups A. C. Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, is indicated for active immunization to prevent invasive meningococcal disease caused by N meningitidis serogroups A. C. Y and W-135. Menactra…

Dressol-X Radiopaque D-502

Aspirin

By Rainbow Specialty & Health Products, Inc. | Last revised: 13 December 2011
Dressol-X Radiopaque D-502

For Dry Sockets: cut off a 2″ strip and roll into toothpick shape. Pack firmly entire socket from the base up the walls. Cut away excess material. Finish plug with fingertip pressure. After 4-5 days, remove all components from socket. See insert for…

Buprenorphine Hydrochloride

Buprenorphine Hydrochloride

By Janssen Pharmaceutica NV | Last revised: 14 December 2011
Buprenorphine Hydrochloride

R 036869 BUPRENORPHINE HYDROCHLORIDE (N*) CODE NO.: 496285. LOT: PACK: GROSS: TARE: NET: R 39/23 Giftig: Gevaar voor ernstige onherstelbare effecten bij inademing. R 22 Schadelijk bij opname door de mond. R 43 Kan gevoeligmaking veroorzaken bij…

RiaSTAP

Fibrinogen

By CSL Behring GmbH | Last revised: 19 December 2011
RiaSTAP

RiaSTAP ®. Fibrinogen Concentrate (Human) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. The effectiveness of RiaSTAP is based on maximum…

Page 1 of 2 1 2 »